NRx’s Home Therapeutics Closes Dura Medical Acquisition

Investors and healthcare professionals, Home Therapeutics—a subsidiary of clinical-stage biotech company NRx Pharmaceuticals—has officially closed the acquisition of Dura Medical, a leader in interventional psychiatric care based in Florida.

The deal, along with pending acquisitions of NeuraSpa TMS and Cohen & Associates, will support a growing network of more than eight clinical care sites across the West Coast of Florida. Dura Medical specializes in treating depression, PTSD, and chronic pain using cutting-edge techniques like ketamine infusion therapy and transcranial magnetic stimulation (TMS), offering a full continuum of psychiatric care.

Catch the full NewsOut update from the floor of the New York Stock Exchange with Jane King.

🏷️ Tags:

#HomeTherapeutics
#NRxPharmaceuticals
#DuraMedical
#MentalHealthCare
#KetamineTherapy
#TMS
#DepressionTreatment
#BiotechNews
#JaneKing
#NewsOut
#HealthcareInvesting
#FloridaHealthcare
#ClinicalCare
#PTSDTreatment
#ChronicPainTherapy